Business
Solanbridge Group Inc. Finalizing Acquisition of Colorado Medical Marijuana Product Producer
Solanbridge Group Inc. Finalizing Acquisition of Colorado Medical Marijuana Product Producer.
About this update from Solanbridge Group Inc
[{"type":"text","content":"\n\n\n\nSolanbridge Group Inc. Finalizing Acquisition of Colorado Medical Marijuana Product Producer\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nSolanbridge Group Inc. Finalizing Acquisition of Colorado Medical Marijuana Product Producer\nPR Newswire\nHOUSTON, May 5, 2014\n\n\n\nHOUSTON, May 5, 2014 /PRNewswire/ -- Solanbridge Group Inc. (OTC: SLNX) is in the final negotiations to acquire a Colorado health product producer whose products are derived from naturally occurring cannabinoids and, in particular, cannabidiol (CBD). CBD is related to tetrahydrocannabinol (the psychoactive constituent of the cannabis plant).  CBD possesses no psychoactive properties and therefore is a ready for market marijuana based ingredient.  The negotiations for the acquisition are in their final stages and we should have an announcement in the next week or two.\n\nDr. Mark T. Cullen, chair of the Scientific Advisory Board of SLNX stated, \"We are looking forward to working with our new acquisition candidate to develop medical marijuana products for rheumatoid arthritis and Alzheimer's.  There is great work currently being done in the treatment of brain damage, severe social anxiety, cancer, and psychological disorders and we are excited to be a part of that work.\"\n\nCharles R. Shirley, Chairman of the Board and Managing Director of SLNX stated, \"Dr. Cullen's amazing career as a medical doctor, a chemist, a researcher, and as an entrepreneur will add tremendous value to what the group in Colorado has already started.\" Colorado, of course, has already approved medical marijuana and recreational marijuana use. Shirley added, \"With this acquisition, which is a just few days away from completion, SLNX will be able to begin work on CBD-infused products immediately without having an indeterminate wait for licenses or other regulatory issues.\" \n\nDr. Cullen's resume fits nicely with the development of medical marijuana products. He is a Yale University-trained doctor and medical director, who had academic appointments at Yale University and University of Florida.  Dr....